Assignment: Read the following resources and answer the questions below. · Morga
ID: 126479 • Letter: A
Question
Assignment: Read the following resources and answer the questions below.
· Morgan SL and Baggott JE. Medical Foods: Products for the Management of Chronic Diseases. Nutrition Reviews 2006; 64(11):495-501.
· FDA: Draft Guidance for Industry: Frequently Asked Questions About Medical Foods, 2nd Edition. Revised May 2016. http://www.fda.gov/downloads/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/UCM500094.pdf
Questions/Discussion Items:
1. Compare and contrast the regulatory differences between medical foods, drugs, and dietary supplements?
a. Such as: governing regulation, intended population, ingredients, product basis, safety standard, scientific requirement, physician supervision, dosing, distribution
2. Describe the regulatory criteria that provide the legal definition of a medical food. (hint: 5 criteria)
3. Do medical foods require a prescription prior to dispensing? Defend your answer.
4. What is the FDA’s position on the use of the “Rx only” and National Drug Code (NDC) numbers on labeling of medical foods?
5. What is an inborn error of metabolism (IEMs)?
a. Identify a few examples of IEMs?
Explanation / Answer
1. Compare and contrast the regulatory differences between medical foods, drugs, and dietary supplements?
a. Such as: governing regulation, intended population, ingredients, product basis, safety standard, scientific requirement, physician supervision, dosing, distribution
All solution and non-physician recommended drugs are controlled in the United States by the Food and Drug Administration (FDA). In any case, dietary supplements are dealt with more like extraordinary sustenances.
Since supplements aren't considered medications, they aren't put through the same strict wellbeing and adequacy necessities that medications are. So every one of the medications you can purchase, even without a medicine, must be demonstrated sheltered and compelling – yet dietary supplements don't.
Medications are viewed as dangerous until demonstrated safe
When all is said in done, the FDA views new medications as perilous until the point when they are demonstrated safe through clinical trials. What's more, the FDA must support any new medication before it can be lawfully sold in the US. Clinical trials are thinks about done under very much controlled conditions on human volunteers. These tests must be done on all medications – even those that are sold over the counter (without a remedy). The FDA endorsement process requires that the medication be demonstrated in a progression of clinical trials. These investigations must show "considerable confirmation" that the medication is both protected and powerful for each of its planned employments.
Once the FDA endorses the medication, it must be produced under precisely observed conditions and bundled with finish data on the best dosage, course, and calendar. The bundle data should likewise include:
Conditions the medication has been demonstrated to treat Known reactions
Contraindications (extraordinary conditions under which utilizing the medication ought not be utilized in light of the fact that it would cause excessively hazard)
Hazardous communications with different medications
Once the overall population is utilizing another medication, the FDA follows up on any evil impacts patients and their specialists report (see "How to report antagonistic responses" in the segment called " Guidelines for picking dietary supplements securely"). The medication organization is required to record data they get about symptoms also. This information guarantees that any reactions not found in the clinical trials will in the long run be found and followed for the security of other individuals.
While fake medications are some of the time made and flowed, they don't generally get into wide course unless they're being appropriated outside of the typical channels, (for example, from undocumented web drug stores). This is on account of medications are normally observed by specialists, drug specialists, and attendants. At the point when fake medications do make it into the framework, wellbeing experts frequently see the distinctions accordingly between the genuine and phony medications with the goal that they are gotten rapidly. The FDA makes snappy move when these issues are found.
Dietary supplements are viewed as protected until demonstrated dangerous
2. Describe the regulatory criteria that provide the legal definition of a medical food. (hint: 5 criteria)
FDA has set up by control any criteria that clear up the meaning of a therapeutic nourishment
The accompanying criteria that elucidate the meaning of a therapeutic nourishment can be found in FDA's directions at 21 CFR 101.9(j)(8). A restorative sustenance is absolved from the sustenance naming prerequisites of 21 CFR 101.9 just if:
a. It is an uncommonly planned and prepared item (rather than a normally happening foodstuff utilized as a part of its normal state) for the halfway or restrictive bolstering of a patient by methods for oral admission or enteral sustaining by tube, which means a tube or, on the other hand catheter that conveys supplements past the oral depression specifically into the stomach or little intestine;
b. It is proposed for the dietary administration of a patient who, in view of restorative or interminable therapeutic needs, has restricted or weakened ability to ingest, process, assimilate, or use customary foodstuffs or certain supplements, or who has other extraordinary therapeutically decided supplement necessities, the dietary administration of which can't be accomplished by the change of the typical eat less carbs alone;
c. It gives healthful help particularly adjusted to the administration of the one of a kind supplement needs that outcome from the particular ailment or condition, as controlled by therapeutic assessment;
d. It is expected to be utilized under therapeutic supervision; and
e. It is expected just for a patient getting dynamic and progressing medicinal supervision wherein the patient requires medicinal care on a repeating reason for, in addition to other things, guidelines on the utilization of the therapeutic nourishment.
3. Do medical foods require a prescription prior to dispensing? Defend your answer.
No. The necessity for a composed or oral remedy in area 503(b) of the FD&C Act and its actualizing controls at 21 CFR 201.100 just applies to the apportioning of physician endorsed medicate items. The Orphan Drug Act gives that restorative nourishments must be figured to be devoured or controlled enterally under the supervision of a doctor, however there is no prerequisite for a solution.
A medicinal nourishment, as characterized in segment 5(b)(3) of the Orphan Drug Act (21 U.S.C. 360ee(b)(3)), is "a sustenance which is planned to be expended or controlled enterally under the supervision of a doctor and which is expected for the particular dietary administration of an infection or condition for which unmistakable nutritious prerequisites, in view of perceived logical standards, are built up by restorative assessment."
FDA considers the meaning of therapeutic nourishments to barely compel the sorts of items that fit inside this classification of nourishment (21 CFR 101.9(j)(8)). Restorative sustenances are recognized from the more extensive class of nourishments for unique dietary use by the prerequisite that therapeutic nourishments be planned to meet unmistakable wholesome prerequisites of a malady or condition, utilized under restorative supervision, and planned for the particular dietary administration of a malady or condition. Restorative sustenances are most certainly not those essentially suggested by a doctor as a component of a general eating regimen to deal with the manifestations or decrease the danger of a malady or condition. Not all nourishments encouraged to patients with an illness, including infections that require dietary administration, are medicinal sustenances.
Rather, medicinal nourishments are sustenances that are extraordinarily detailed and prepared (as contradicted to a normally happening foodstuff utilized as a part of a characteristic state) for a patient who requires utilization of the item as a noteworthy part of a malady or condition's particular dietary administration.
4. What is the FDA’s position on the use of the “Rx only” and National Drug Code (NDC) numbers on labeling of medical foods?
FDA considers the prerequisite that a medicinal sustenance be detailed to be devoured or regulated enterally under the supervision of a doctor to imply that the proposed utilization of a medicinal sustenance is for the dietary administration of a patient accepting dynamic and progressing therapeutic supervision (e.g., in a human services office or as an outpatient) by a doctor who has verified that the therapeutic nourishment is important to the patient's general medicinal care. The patient ought to by and large observe the doctor on a repeating reason for, in addition to other things, directions on the utilization of the therapeutic sustenance as a major aspect of the dietary administration of a given malady or condition.
The naming of therapeutic nourishments may not hold up under the image "Rx as it were." Section 503(b)(4)(A) of the FD&C Act (21 U.S.C. 353(b)(4)(A)) gives that a solution tranquilize is misbranded if the name of the medication neglects to endure, at the very least, the image "Rx just" to demonstrate that the item may not legally be apportioned without a medicine. Not at all like doctor prescribed medications, medicinal nourishments are not required by government law to be administered by remedy. In this manner, the utilization of the image "Rx just" in the marking of a restorative nourishment would misbrand a medicinal sustenance under segment 403(a)(1) of the FD&C Act since it would be a false and deluding articulation about that item. In any case, since restorative nourishments are required by statute to be detailed to be expended or directed enterally under the supervision of a doctor, FDA would not protest the utilization of dialect to impart this necessity in the marking of a restorative sustenance item that isn't false or deceiving (e.g., "must be utilized under the supervision of a doctor").
5. What is an inborn error of metabolism (IEMs)?
FDA for the most part views IEMs as maladies or conditions that a therapeutic nourishment could be utilized to oversee. IEMs incorporate acquired biochemical issue in which a particular catalyst imperfection meddles with the typical digestion of protein, fat, or sugar. Because of lessened or missing compound movement in these clutters, certain mixes amass in the body to dangerous levels, and levels of other intensifies that the body typically makes may end up noticeably insufficient. Without fitting and open administration, these metabolic unsettling influences can prompt a host of medicinal and formative results extending from scholarly handicap to serious intellectual hindrance and even demise. Administration may incorporate one or a blend of the accompanying: tranquilize treatment, adjustment of the typical eating regimen, or, on the other hand utilization of a restorative food. Some of these disarranges can be made do with adjustment of the typical eating routine alone (e.g., decrease of galactose and lactose for galactosemia). Be that as it may, others can't be overseen exclusively with consume less calories alteration. For these IEMs, a medicinal nourishment is required notwithstanding a particular dietary adjustment keeping in mind the end goal to acquire satisfactory levels of basic supplements (e.g., basic amino acids, basic unsaturated fats) that are confined by changing the ordinary eating regimen. Medicinal sustenances wind up plainly essential for people with these IEMs keeping in mind the end goal to meet the day by day prerequisites of basic supplements and to constrain the metabolic unsettling influences related with the specific IEM.
a.Identify a few examples of IEMs?
A few cases of particular IEMs that therapeutic sustenances could be utilized to oversee include amino corrosive/protein, natural corrosive, or unsaturated fat digestion. These IEMs principally require noteworthy limitation of specific amino acids as well as aggregate protein for example, in phenylketonuria (phenylalanine limitation), ornithine transcarbamylase inadequacy (insignificant amino corrosive limitation), methylmalonic acidemia (isoleucine, methionine, threonine, and valine confinement), or noteworthy alteration of greasy acids/add up to fat, for example, in long-chain acyl-CoA dehydrogenase lack (long chain unsaturated fat confinement with an expansion in medium chain unsaturated fat levels).
Related Questions
drjack9650@gmail.com
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.